Merck KGaA agreed to sell the German drugmaker’s allergy business Allergopharma to Dermapharm SE for an undisclosed price, but will continue to develop an autoinjector to treat allergic shock.
If you have received a vaccination, hip replacement or chemotherapy without suffering toxic shock, chances are you have benefited from a vast bloodletting of horseshoe crabs.
